NGNE 8-K: SEC filing

Filed with the SEC on Nov 9, 2026 · accession 0001404644-26-000064

NGNE filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Neurogene Inc. furnished a Form 8-K reporting its financial results for the quarter ended September 30, 2026, and posted an updated corporate presentation on its website.

For details, click here →How to read a 8-K →

Key details

RegistrantNeurogene Inc.

President, chief financial officerChristine Mikail

✦ Ask GOAX AI about this filing — what it means for NGNE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NGNE?

Click here

Frequently asked questions

What did NGNE file with the SEC on Nov 9, 2026?

NGNE filed a 8-K (SEC filing). Neurogene Inc. furnished a Form 8-K reporting its financial results for the quarter ended September 30, 2026, and posted an updated corporate presentation on its website.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other NGNE SEC filings

Get alerts when NGNE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

NGNE overview NGNE analysis NGNE news Latest SEC filings